UniProt ID | CAH9_HUMAN | |
---|---|---|
UniProt AC | Q16790 | |
Protein Name | Carbonic anhydrase 9 | |
Gene Name | CA9 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 459 | |
Subcellular Localization |
Nucleus . Nucleus, nucleolus . Cell membrane Single-pass type I membrane protein . Cell projection, microvillus membrane Single-pass type I membrane protein . Found on the surface microvilli and in the nucleus, particularly in nucleolus. |
|
Protein Description | Reversible hydration of carbon dioxide. Participates in pH regulation. May be involved in the control of cell proliferation and transformation. Appears to be a novel specific biomarker for a cervical neoplasia.. | |
Protein Sequence | MAPLCPSPWLPLLIPAPAPGLTVQLLLSLLLLVPVHPQRLPRMQEDSPLGGGSSGEDDPLGEEDLPSEEDSPREEDPPGEEDLPGEEDLPGEEDLPEVKPKSEEEGSLKLEDLPTVEAPGDPQEPQNNAHRDKEGDDQSHWRYGGDPPWPRVSPACAGRFQSPVDIRPQLAAFCPALRPLELLGFQLPPLPELRLRNNGHSVQLTLPPGLEMALGPGREYRALQLHLHWGAAGRPGSEHTVEGHRFPAEIHVVHLSTAFARVDEALGRPGGLAVLAAFLEEGPEENSAYEQLLSRLEEIAEEGSETQVPGLDISALLPSDFSRYFQYEGSLTTPPCAQGVIWTVFNQTVMLSAKQLHTLSDTLWGPGDSRLQLNFRATQPLNGRVIEASFPAGVDSSPRAAEPVQLNSCLAAGDILALVFGLLFAVTSVAFLVQMRRQHRRGTKGGVSYRPAEVAETGA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
47 | Phosphorylation | LPRMQEDSPLGGGSS CCCCCCCCCCCCCCC | 22.67 | 26657352 | |
53 | Phosphorylation | DSPLGGGSSGEDDPL CCCCCCCCCCCCCCC | 38.14 | 26657352 | |
54 | Phosphorylation | SPLGGGSSGEDDPLG CCCCCCCCCCCCCCC | 49.85 | 26657352 | |
67 | Phosphorylation | LGEEDLPSEEDSPRE CCCCCCCCCCCCCCC | 62.00 | 26657352 | |
71 | Phosphorylation | DLPSEEDSPREEDPP CCCCCCCCCCCCCCC | 29.18 | 26657352 | |
102 | Phosphorylation | LPEVKPKSEEEGSLK CCCCCCCCCCCCCCC | 59.78 | 26657352 | |
107 | Phosphorylation | PKSEEEGSLKLEDLP CCCCCCCCCCHHCCC | 26.13 | 28857561 | |
115 | O-linked_Glycosylation | LKLEDLPTVEAPGDP CCHHCCCCCCCCCCC | 37.97 | 18703501 | |
304 | Phosphorylation | EEIAEEGSETQVPGL HHHHHHCCCCCCCCC | 40.53 | 22210691 | |
306 | Phosphorylation | IAEEGSETQVPGLDI HHHHCCCCCCCCCCH | 36.24 | 22210691 | |
346 | N-linked_Glycosylation | GVIWTVFNQTVMLSA CCHHHHCCCEEEECH | 32.07 | 18703501 | |
443 | Phosphorylation | RRQHRRGTKGGVSYR HHHHHCCCCCCCCCC | 25.38 | 22037869 | |
448 | Phosphorylation | RGTKGGVSYRPAEVA CCCCCCCCCCHHHHH | 20.78 | 25463755 | |
449 | Phosphorylation | GTKGGVSYRPAEVAE CCCCCCCCCHHHHHC | 20.43 | 8084592 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
443 | T | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CAH9_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CAH9_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CTNB1_HUMAN | CTNNB1 | physical | 14567991 | |
CADH1_HUMAN | CDH1 | physical | 14567991 | |
CTNA1_HUMAN | CTNNA1 | physical | 14567991 | |
FLOT1_HUMAN | FLOT1 | physical | 22939629 | |
CAND1_HUMAN | CAND1 | physical | 23181366 | |
G3BP2_HUMAN | G3BP2 | physical | 23181366 | |
ATPA_HUMAN | ATP5A1 | physical | 23181366 | |
ATPB_HUMAN | ATP5B | physical | 23181366 | |
RTCB_HUMAN | RTCB | physical | 23181366 | |
RS5_HUMAN | RPS5 | physical | 23181366 | |
CAND2_HUMAN | CAND2 | physical | 23181366 | |
ACACA_HUMAN | ACACA | physical | 23181366 | |
IPO9_HUMAN | IPO9 | physical | 23181366 | |
IPO4_HUMAN | IPO4 | physical | 23181366 | |
IPO5_HUMAN | IPO5 | physical | 23181366 | |
IPO7_HUMAN | IPO7 | physical | 23181366 | |
IMA1_HUMAN | KPNA2 | physical | 23181366 | |
XPO5_HUMAN | XPO5 | physical | 23181366 | |
XPOT_HUMAN | XPOT | physical | 23181366 | |
XPO2_HUMAN | CSE1L | physical | 23181366 | |
XPO1_HUMAN | XPO1 | physical | 23181366 | |
TNPO3_HUMAN | TNPO3 | physical | 23181366 | |
TNPO1_HUMAN | TNPO1 | physical | 23181366 | |
ATX10_HUMAN | ATXN10 | physical | 23181366 | |
CAH2_HUMAN | CA2 | physical | 23181366 | |
HEAT3_HUMAN | HEATR3 | physical | 23181366 | |
SAAL1_HUMAN | SAAL1 | physical | 23181366 | |
SRPRB_HUMAN | SRPRB | physical | 23181366 | |
ECHA_HUMAN | HADHA | physical | 23181366 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
H00021 | Renal cell carcinoma | |||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
D00218 | Acetazolamide (JP16/USP/INN); Diamox (TN) | |||||
D00219 | Acetohexamide (JP16/USP/INN); Dymelor (TN) | |||||
D00518 | Diclofenamide (JP16/INN); Dichlorphenamide (USP); Daranide (TN) | |||||
D00652 | Brinzolamide (JAN/USP/INN); Azopt (TN) | |||||
D00653 | Dorzolamide hydrochloride (JP16/USP); Trusopt (TN) | |||||
D00655 | Methazolamide (JAN/USP/INN); Neptazane (TN) | |||||
D01196 | Acetazolamide sodium (JAN); Diamox (TN) | |||||
D01822 | Clofenamide (JAN/INN) | |||||
D02441 | Ethoxzolamide; Cardrase (TN) | |||||
D03845 | Sezolamide hydrochloride (USAN) | |||||
D07871 | Dorzolamide (INN); Trusopt (TN) | |||||
D09593 | Girentuximab (USAN/INN) | |||||
D09632 | Iodine (124I) girentuximab (USAN/INN) | |||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Crystal structure of the catalytic domain of the tumor-associatedhuman carbonic anhydrase IX."; Alterio V., Hilvo M., Di Fiore A., Supuran C.T., Pan P., Parkkila S.,Scaloni A., Pastorek J., Pastorekova S., Pedone C., Scozzafava A.,Monti S.M., De Simone G.; Proc. Natl. Acad. Sci. U.S.A. 106:16233-16238(2009). Cited for: X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 137-391 IN COMPLEX WITH ZINCION AND THE INHIBITOR ACETAZOLAMIDE, GLYCOSYLATION AT ASN-346,DISULFIDE BOND, SUBUNIT, AND BIOPHYSICOCHEMICAL PROPERTIES. | |
"Biochemical characterization of CA IX, one of the most activecarbonic anhydrase isozymes."; Hilvo M., Baranauskiene L., Salzano A.M., Scaloni A., Matulis D.,Innocenti A., Scozzafava A., Monti S.M., Di Fiore A., De Simone G.,Lindfors M., Janis J., Valjakka J., Pastorekova S., Pastorek J.,Kulomaa M.S., Nordlund H.R., Supuran C.T., Parkkila S.; J. Biol. Chem. 283:27799-27809(2008). Cited for: FUNCTION, SUBUNIT, INDUCTION, GLYCOSYLATION AT THR-115 AND ASN-346,AND DISULFIDE BONDS. | |
O-linked Glycosylation | |
Reference | PubMed |
"Biochemical characterization of CA IX, one of the most activecarbonic anhydrase isozymes."; Hilvo M., Baranauskiene L., Salzano A.M., Scaloni A., Matulis D.,Innocenti A., Scozzafava A., Monti S.M., Di Fiore A., De Simone G.,Lindfors M., Janis J., Valjakka J., Pastorekova S., Pastorek J.,Kulomaa M.S., Nordlund H.R., Supuran C.T., Parkkila S.; J. Biol. Chem. 283:27799-27809(2008). Cited for: FUNCTION, SUBUNIT, INDUCTION, GLYCOSYLATION AT THR-115 AND ASN-346,AND DISULFIDE BONDS. | |
Phosphorylation | |
Reference | PubMed |
"The role of carbonic anhydrase IX overexpression in kidney cancer."; Dorai T., Sawczuk I.S., Pastorek J., Wiernik P.H., Dutcher J.P.; Eur. J. Cancer 41:2935-2947(2005). Cited for: PHOSPHORYLATION AT TYR-449. |